SCHEMBL19974112

SCHEMBL19974112

CSc1ccccc1-c1ccc(Br)c2nsnc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 9/20 0.39
▸ MAPT P10636 4/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ LMNA P02545 3/20 0.36
▸ RXFP1 Q9HBX9 3/20 0.36
▸ IDO1 P14902 1/20 0.36
▸ ALDH1A1 P00352 8/20 0.36
▸ RAB9A P51151 6/20 0.36
▸ HPGD P15428 4/20 0.36
▸ SMN1; SMN2 Q16637 4/20 0.36
▸ NISCH Q9Y2I1 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36
▸ NPC1 O15118 5/20 0.34
▸ NPSR1 Q6W5P4 3/20 0.34
▸ PPARG P37231 1/20 0.34
▸ NCOA2 Q15596 1/20 0.34
▸ NCOA1 Q15788 1/20 0.34
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20428806 0.79 MAPT (0.40) KDM4EMAPTMAPK1ALDH1A1NPSR1
SCHEMBL19974109 0.76 TXNRD1 (0.46) MAPTLMNAALDH1A1SMN1; SMN2KMT2A
SCHEMBL23056088 0.76 ALDH1A1 (0.45) KDM4EMAPTMAPK1LMNARXFP1
SCHEMBL23055925 0.73 MAPK1 (0.44) KDM4EMAPTMAPK1ALDH1A1RAB9A
SCHEMBL19988641 0.73 HTT (0.48) KDM4EMAPTLMNARXFP1IDO1
SCHEMBL19988603 0.73 KDM4E (0.33) KDM4EMAPTLMNARXFP1IDO1
SCHEMBL14951410 0.72 ALDH1A1 (0.44) KDM4EMAPTMAPK1LMNARXFP1
SCHEMBL246997 0.71 MAPT (0.44) KDM4EMAPTMAPK1ALDH1A1NPSR1
SCHEMBL31087243 0.71 KDM4E (0.52) KDM4EMAPTLMNARXFP1IDO1
SCHEMBL5890646 0.71 KDM4E (0.52) KDM4EMAPTLMNARXFP1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512848-B1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2020-11-18 — — EP disclosed
EP-3512848-B1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2020-11-18 — — EP disclosed
EP-3512848-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES Merck Patent GmbH (DE) 2019-07-24 — — EP disclosed
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2019-07-11 — — US disclosed
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2019-07-11 — — US disclosed
WO-2018050583-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2018-03-22 — — WO disclosed
WO-2018050583-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2018-03-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES CYCS, CYP3A4, CYP2E1 KDM4E 2638/4885MAPT 2010/4885MAPK1 2992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback